<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">TIH</journal-id>
<journal-id journal-id-type="hwp">sptih</journal-id>
<journal-id journal-id-type="nlm-ta">Toxicol Ind Health</journal-id>
<journal-title>Toxicology and Industrial Health</journal-title>
<issn pub-type="ppub">0748-2337</issn>
<issn pub-type="epub">1477-0393</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0748233711422732</article-id>
<article-id pub-id-type="publisher-id">10.1177_0748233711422732</article-id>
<title-group>
<article-title>Prevention of rat breast cancer by genistin and selenium</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Hamdy</surname>
<given-names>Soha M</given-names>
</name>
<xref ref-type="aff" rid="aff1-0748233711422732">1</xref>
<xref ref-type="corresp" rid="corresp1-0748233711422732"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Latif</surname>
<given-names>Abdel Karim M Abdel</given-names>
</name>
<xref ref-type="aff" rid="aff2-0748233711422732">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Drees</surname>
<given-names>Ehab A</given-names>
</name>
<xref ref-type="aff" rid="aff1-0748233711422732">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Soliman</surname>
<given-names>Sahar M</given-names>
</name>
<xref ref-type="aff" rid="aff1-0748233711422732">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-0748233711422732"><label>1</label>Chemistry Department, Faculty of Science, El Fayoum University, El-Fayoum, Egypt</aff>
<aff id="aff2-0748233711422732"><label>2</label>Zoology Department, Faculty of Science, El Fayoum University, El-Fayoum, Egypt</aff>
<author-notes>
<corresp id="corresp1-0748233711422732">Soha M Hamdy, Biochemistry Division, Chemistry Department, Faculty of Science, Fayoum University, Fayoum, Egypt Email: <email>soha967@yahoo.com</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>9</month>
<year>2012</year>
</pub-date>
<volume>28</volume>
<issue>8</issue>
<fpage>746</fpage>
<lpage>757</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>Breast cancer is the second leading cause of cancer death among women and the third most common cancer. In this study, we investigated the chemoprevention efficacy of each of soy genistin, selenium or a combination of them against breast cancer. Seventy-five female rats were divided into five groups : control group (I); 7,12-dimethylbenz(a)anthracene (DMBA) group (II); DMBA treated with genistin group (III); DMBA treated with selenium group (IV); and DMBA treated with genistin combined with selenium group (V). The treatments were daily administered for 3 months. There were a significant decrease in body weight and serum total antioxidant, while a significant elevation in serum total sialic acid, carcinoembryonic antigen, prolactin, estradiol, nitric oxide, and malondialdhyde of DMBA injected rats compared with control group. Administration of genistin and selenium was associated with decreasing levels of tumorigenicity, endocrine derangement, and oxidative stress. Formation of breast carcinoma in DMBA-induced rats and abnormal changes were ameliorated in the rats treated with genistin/selenium or genistin alone. Supplementation of genistin alone or with selenium provided antioxidant defense with high-potential chemopreventive activity against DMBA-induced mammary tumors more than selenium alone.</p>
</abstract>
<kwd-group>
<kwd>Breast cancer</kwd>
<kwd>genistin</kwd>
<kwd>selenium</kwd>
<kwd>DMBA</kwd>
<kwd>TSA</kwd>
<kwd>CEA</kwd>
<kwd>MDA</kwd>
<kwd>prolactin</kwd>
<kwd>estrogen</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-0748233711422732">
<title>Introduction</title>
<p>Breast cancer is the most common cancer and the second principal cause of cancer deaths in women worldwide as well as in Egypt (Abd El Aziz et al., <xref ref-type="bibr" rid="bibr1-0748233711422732">2009</xref>). Over the last few years, cancer registries in North Africa (Morocco, Algeria, Tunisia, Libya and Egypt) increased in number from one to nine, and now covers 13% of the total regional population. The total cancer burden in the North African countries is between one third and one half of what is observed in Europe (<xref ref-type="bibr" rid="bibr78-0748233711422732">Zanetti et al., 2009</xref>). Not only genetic factors but also life-style factors, such as diet, play an important role in disease etiology. It has been estimated that about one third of all human cancers are related to the modern diet (<xref ref-type="bibr" rid="bibr15-0748233711422732">Doll and Peto, 1981</xref>; <xref ref-type="bibr" rid="bibr56-0748233711422732">Peto, 2001</xref>). It has been suggested that a high intake of fruits and vegetables to be a valid tool for cancer prevention (<xref ref-type="bibr" rid="bibr68-0748233711422732">Tadjalli-Mehr et al., 2003</xref>). Certain dietary components are associated with lower cancer risk, including vitamins, turmeric, selenium, green tea, soy, folate, beta-carotene and tomatoes which are important in altering cancer initiation, promotion, and progression, as well as in the prevention of cancer (<xref ref-type="bibr" rid="bibr6-0748233711422732">Barnes et al., 1990</xref>). It has been found that eating soy during childhood, adolescence, and adulthood are all associated with a decreased risk of breast cancer and the effect was strongest when soy foods were eaten during childhood (<xref ref-type="bibr" rid="bibr36-0748233711422732">Korde et al., 2009</xref>). <xref ref-type="bibr" rid="bibr27-0748233711422732">Guha et al. (2009</xref>) suggests that women diagnosed with breast cancer who regularly consume soy may actually have a reduced risk of recurrence. Furthermore, no evidence exist that soy, or its bioactive compounds, caused changes associated with human breast cancer, such as thickened breast tissue (<xref ref-type="bibr" rid="bibr46-0748233711422732">Maskarinec et al., 2004</xref>; <xref ref-type="bibr" rid="bibr45-0748233711422732">Maskarinec et al., 2009</xref>), increased number of breast tissue cells (<xref ref-type="bibr" rid="bibr53-0748233711422732">Palomares et al., 2004</xref>), or increased estrogen circulating in the blood (<xref ref-type="bibr" rid="bibr41-0748233711422732">Kurzer, 2002</xref>). The prevalence of hormone-dependent tumors such as breast or prostate cancer is significantly lower in Asia than in Western countries. This observation has been attributed to the high consumption of soy products in Asia and specifically to the fraction of isoflavones (<xref ref-type="bibr" rid="bibr60-0748233711422732">Qin et al., 2006</xref>; Verheus et al., 2007). Epidemiological and clinical data rather point to cancer protective effects of soy isoflavones at a dose of 50–200 mg per day (<xref ref-type="bibr" rid="bibr33-0748233711422732">Iwasaki et al., 2008</xref>). Several mechanisms have been proposed by which estrogen may exert a procarcinogenic effect (<xref ref-type="bibr" rid="bibr8-0748233711422732">Cavalieri et al., 1997</xref>; <xref ref-type="bibr" rid="bibr20-0748233711422732">Ethier, 1995</xref>; <xref ref-type="bibr" rid="bibr22-0748233711422732">Fishman et al., 1995</xref>; <xref ref-type="bibr" rid="bibr50-0748233711422732">Nandi et al., 1995</xref>). The main dietary source of genistein is the biologically active glucoside genistin. Digestion of soybeans or soy products results in the release of the sugar molecule from the isoflavone glycoside, genistin, leaving the isoflavone aglycone, genistein (<xref ref-type="bibr" rid="bibr64-0748233711422732">Rowland et al., 2003</xref>). <xref ref-type="bibr" rid="bibr39-0748233711422732">Kuiper et al., (1998</xref>) reported that the binding affinity of genistein for estrogen receptor alpha (ER-α) was 4%, and for ER-β was 87%, compared to estradiol. Thus, by interaction with ER, genistein blocks the binding of more potent estrogens at the same time and affects estrogen metabolism, thereby exerting a potential favorable role in the prevention of hormone-related cancers. Both ERs are present in breast tissue, but in breast tumors the ratio of ER-α to ER-β is increased and expression of ER-β is associated with low aggressiveness of breast tumors compared with those with ER-β-negative tumors, while the activation of ER-α is known to promote breast tumor growth (<xref ref-type="bibr" rid="bibr65-0748233711422732">Saji et al., 2005</xref>).</p>
<p>Selenium (Se) is an essential trace element in the human body, The Se content in food principally depends on the concentration and physicochemical forms existing in the soil (<xref ref-type="bibr" rid="bibr69-0748233711422732">Tato Rocha et al., 1994</xref>). Selenium metabolism in the body is influenced by chemical forms of selenium. Organic Se is present in foods mainly in the form of selenomethionine, selenocysteine and Se-methylselenocysteine. Whereas inorganic Se either as selenite or as selenate occurs much less frequently and in very low amounts. Both organic and inorganic forms of Se appear to be utilized with similar efficacy in the body to produce selenoproteins (<xref ref-type="bibr" rid="bibr67-0748233711422732">Shiobara et al., 1998</xref>). A diet containing Se could be beneficial in the treatment of diseases correlated with considerable oxidative stress (<xref ref-type="bibr" rid="bibr23-0748233711422732">Gabrashanska et al., 2010</xref>). Selenium is an important cofactor of various antioxidant enzymes and has been shown to enhance DNA repair in normal human fibroblasts. Oral selenium supplementation has also been shown to decrease the number of chromosome breaks in <italic>BRCA1</italic> mutation carriers (<xref ref-type="bibr" rid="bibr37-0748233711422732">Kotsopoulos et al., 2010</xref>), where the inorganic (e.g., selenite, selenate) and some naturally occurring selenium-containing amino acids (e.g., selenomethionine) were equally effective chemopreventive agents but had comparable toxicity (<xref ref-type="bibr" rid="bibr76-0748233711422732">Zachara and Pilecki, 2001</xref>).</p>
<p>Evidence from epidemiological, cell, animal, and clinical studies suggests that selenium may play a preventive and/or anticarcinogenic role in the development of breast cancer. A number of studies have confirmed that women with breast cancer have lower blood selenium concentrations than those of healthy controls (<xref ref-type="bibr" rid="bibr10-0748233711422732">Charalabopoulos et al., 2006</xref>; <xref ref-type="bibr" rid="bibr31-0748233711422732">Huang et al., 1999</xref>). Also Se is found to be a component of several other selenoproteins, some of which have important enzymatic functions associated with antioxidant defenses. One of these, thioredoxin reductase is considered a key enzyme in Se metabolism, reducing Se compounds and controlling the intracellular redox state (<xref ref-type="bibr" rid="bibr42-0748233711422732">Lee et al., 2000</xref>; Madeja et al., 2005). Another selenoprotein, selenoprotein P, appears to protect endothelial cells against damage from free radicals (<xref ref-type="bibr" rid="bibr3-0748233711422732">Allan et al., 1999</xref>; Ganther, 1999; <xref ref-type="bibr" rid="bibr61-0748233711422732">Rayman, 2000</xref>). The relationship between selenium and estrogen may stem from the presence of an estrogen response element (ERE) in the promoter region of some selenoprotein genes (<xref ref-type="bibr" rid="bibr7-0748233711422732">Borthwick et al., 2003</xref>). An additional suggestion that selenium is somehow involved with estrogen and breast cancer risk comes from selenium preventive effect on breast cancer being more pronounced after menopause (<xref ref-type="bibr" rid="bibr29-0748233711422732">Hardell et al., 1993</xref>; <xref ref-type="bibr" rid="bibr31-0748233711422732">Huang et al., 1999</xref>). Endogenous nitric oxide (NO<sup>•</sup>) plays a dual role in specialized tissues and cells, which acts an essential physiological signaling molecule mediating various cell functions and also induces cytotoxic and mutagenic effects when present in excess. NO<sup>•</sup> reacts rapidly with superoxide anion to form peroxynitrite, which may be cytotoxic by itself or easily decompose to the highly reactive and toxic hydroxyl radical and nitrogen dioxide (NO<sub>2</sub>) (<xref ref-type="bibr" rid="bibr51-0748233711422732">Ohshima and Bartsch, 1994</xref>). </p>
<p>The aim of the present study is to elucidate whether genistin with or without selenium (Se) or selenium only may elicit a protective or preventive effects against breast cancer in rats induced by 7,12-dimethylbenz(a)anthracene ([DMBA] Sigma Chemicals). Markers of tumorigenicity, markers of endocrine derangement and markers of oxidative stress together with histological examinations of the breast tissue were assessed to highlight the protective or preventive effects of these natural products. </p>
</sec>
<sec id="section2-0748233711422732" sec-type="materials|methods">
<title>Materials and methods</title>
<p>Seventy-five female Sprague Dawley rats weighing 45–55 g (the Animal House Colony of the National Research Centre, Cairo, Egypt) were maintained and handled according to the recommendations of the Institutional Ethic Committee, on standard laboratory diet and water ad libitum and housed in a temperature-controlled (23 ± 1°C), 40–60% relative humidity and artificially illuminated (12-h dark/light cycle) room. Rats were randomized into five groups (15 rats/group). Group I served as control, Group II as the DMBA group that is the group of tumergenicity, Group III treated with genistin (Sigma Chemicasl) 1200 mg/kg diet (Allred et al., 2001), Group IV treated with sodium selenite (Sigma Chemical) 1.7 mg/kg diet (<xref ref-type="bibr" rid="bibr11-0748233711422732">Chen et al., 2000</xref>), and Group V treated with genistin 1200 mg/kg diet and sodium selenate 1.7 mg/kg diet for 2 weeks. Then the rats in Groups II–V were injected intraperitoneally with a single dose of 10 mg/rat of DMBA (Sigma Chemicals). DMBA was dissolved in 0.5 mL 10% dimethyl sulfoxide (DMSO) (<xref ref-type="bibr" rid="bibr2-0748233711422732">Abd El Aziz et al., 2005</xref>). Groups III-V treated with genistin (1200 mg/kg diet), sodium selenite (1.7 mg/kg diet) and both genistin (1200 mg/kg diet) and sodium selenite (1.7 mg/kg diet), respectively, for 3 months.</p>
<p>After 3 months, the blood samples were collected from the retro-orbital venous plexus under diethyl ether anesthesia and serum was separated after centrifugation at 3000 rpm for 15 min and stored in –20°C for estimation of total sialic acid (TSA) and carcinoembryonic antigen (CEA) as markers for tumorigenicity, prolactin and estradiol as markers of endocrine derangement, NO, malondialdhyde (MDA) and total antioxidant activity as markers for oxidative stress. After blood collection, the rats were killed under anesthesia and mammary tissues of each animal were excised and preserved in formalin for histopathological examination.</p>
<sec id="section3-0748233711422732">
<title>Biochemical analysis</title>
<p>Serum TSA level was determined according to the method described by <xref ref-type="bibr" rid="bibr57-0748233711422732">Plucinsky et al. (1986</xref>); enzyme-linked immunosorbent assay (ELISA) was used for quantitative determination of serum CEA using a kit purchased from Monobind,inc.costa, measa, CA, USA (<xref ref-type="bibr" rid="bibr74-0748233711422732">Wild, 1994</xref>). A serum level of prolactin was measured using ELISA kit purchased from MD Bioproduct, MD Biosciences, Inc., according to <xref ref-type="bibr" rid="bibr17-0748233711422732">Duhau et al., (1991</xref>). ELISA was used for quantitative determination of estradiol concentration in serum using a kit purchased from BioCheck, Inc., according to Tietz et al. (<xref ref-type="bibr" rid="bibr70-0748233711422732">1995</xref>). Serum NO level was determined according to the method of <xref ref-type="bibr" rid="bibr71-0748233711422732">Vodovotz (1996</xref>). The MDA were assayed according to the method of <xref ref-type="bibr" rid="bibr19-0748233711422732">Esterbauer and Cheeseman (1990</xref>). Quantitative determination of total antioxidant capacity in serum was carried out by colorimetric method using a kit purchased from Biodiagnostic, Egypt, according to <xref ref-type="bibr" rid="bibr35-0748233711422732">Koracevic et al. (2001</xref>).</p>
</sec>
<sec id="section4-0748233711422732">
<title>Histopathological investigation</title>
<p>The mammary tissues were taken and fixed in 10% buffered formalin, embedded in pure paraffin wax (melting point of 58 °C) and then mounted into blocks and left at 4°C until the time of use. The paraffin blocks were sectioned on the microtome at thickness of 5 µm and mounted on clean glass slides then left in the oven at 40°C for dryness. The slides were deparafinized in xylol then immersed in descending series of alcohol (90–50). The ordinary hematoxylin and eosin stain were used (<xref ref-type="bibr" rid="bibr16-0748233711422732">Drury and Wallington, 1980</xref>).</p>
</sec>
<sec id="section5-0748233711422732">
<title>Statistical analysis</title>
<p>Data are presented as mean ± standard deviation (SD). One-way analysis of variance (ANOVA) followed by Tukey multiple comparison method was carried out to compare the mean value of different groups using SPSS 7.5 student version 3. Comparisons were made between Group I versus groups II-V, and between group II versus groups III-V. <italic>p</italic> &lt; .05 was considered statistically significant.</p>
</sec>
</sec>
<sec id="section6-0748233711422732">
<title>Results</title>
<p>No rats died in group I, 5 of 15 rats died in Group II. In Group III, 3 of 15 rats died. While in Group IV, 5 of 15 rats died and in Group V 4 of rats 15 died. There was an increase in the body weight in all groups at the time of killing compared to at the start of experiment, with percentage changes 64.8%, 29.11%, 41.18%, 27.37% and 44.15% for Groups I-V, respectively (<xref ref-type="table" rid="table1-0748233711422732">Table 1</xref>). At the end of the experiment, groups II, III, IV and V were significantly decreased in the body weight compared to control group. There was a significant increase in the body weight on rats injected with DMBA supplemented with genistin (Group III), and rats injected with DMBA supplemented with genistin combined with selenium (Group V) compared with rats injected with DMBA only (Group II). On the other hand, there was no significant change in the body weight between rats injected with DMBA supplemented with selenium (Group IV) compared to Group II (<xref ref-type="table" rid="table1-0748233711422732">Table 1</xref>). <xref ref-type="table" rid="table2-0748233711422732">Table 2</xref> shows that both serum levels of TSA and CEA were significantly increased in groups II-V compared with control (Group I) but showed significant decrease in Groups III and V when compared with the DMBA-treated group (Group II) and also showed serum levels of prolactin and estradiol in Groups II and IV were significantly increased when compared with control rats, but there was no significant change in Groups III and V; but compared with Group II there was a significant decrease in Group V and there was no significant change in Groups III and IV in serum prolactin level; serum estradiol level was significantly decreased in Group III, increased in Group V and no significant change in Group IV. <xref ref-type="table" rid="table3-0748233711422732">Table 3</xref> shows the results that the serum level of both NO and MDA were significantly increased in Groups II-V when compared with control rats, in Groups III and V when compared with Group II, but there was no significant change in Group IV compared with Group II; when compared with the control Group I, the serum level of total antioxidants revealed a significant decrease in DMBA-treated Group II, but Groups III–V showed no significant change, but when compared with Group II showed significant increase in Groups III and V but there was a significant change in Group III. </p>
<table-wrap id="table1-0748233711422732" position="float">
<label>Table 1.</label>
<caption>
<p>Mean ± SD of body weight at the start and end of the experiment in different groups<sup><xref ref-type="table-fn" rid="table-fn1-0748233711422732">a</xref></sup>
</p>
</caption>
<graphic alternate-form-of="table1-0748233711422732" xlink:href="10.1177_0748233711422732-table1.tif"/>
<table>
<thead>
<tr>
<th>Groups Parameter</th>
<th>Group I (<italic>n</italic> = 15)</th>
<th>Group II (<italic>n</italic> = 10)</th>
<th>Group III (<italic>n</italic> = 12)</th>
<th>Group IV (<italic>n</italic> = 10)</th>
<th>Group V (<italic>n</italic> = 11)</th>
</tr>
</thead>
<tbody>
<tr>
<td>Body weight at start (gm)</td>
<td>119.6 ± 11.9</td>
<td>116.1 ± 6.5</td>
<td align="center">122 ± 7.7</td>
<td align="center">119.2 ± 6.88</td>
<td align="center">121 ± 7.9</td>
</tr>
<tr>
<td>Body weight at the end of the experiment (gm) (percentage change)</td>
<td>197.1 ± 7.17 	(64. 8%)</td>
<td>149.9 ± 17.77<sup><xref ref-type="table-fn" rid="table-fn2-0748233711422732">b</xref><xref ref-type="table-fn" rid="table-fn3-0748233711422732">c</xref></sup> 	(29.11%)</td>
<td>172.25 ± 11.93<sup><xref ref-type="table-fn" rid="table-fn2-0748233711422732">b</xref><xref ref-type="table-fn" rid="table-fn4-0748233711422732">d</xref>,<xref ref-type="table-fn" rid="table-fn5-0748233711422732">e</xref><xref ref-type="table-fn" rid="table-fn4-0748233711422732">d</xref></sup> 	(41.18 %)</td>
<td>151.83 ± 13.55<sup><xref ref-type="table-fn" rid="table-fn2-0748233711422732">b</xref><xref ref-type="table-fn" rid="table-fn3-0748233711422732">c</xref>,bNS</sup> 	(27.37%)</td>
<td>174.42 ± 15.21<sup><xref ref-type="table-fn" rid="table-fn2-0748233711422732">b</xref><xref ref-type="table-fn" rid="table-fn3-0748233711422732">c</xref>,<xref ref-type="table-fn" rid="table-fn2-0748233711422732">b</xref><xref ref-type="table-fn" rid="table-fn4-0748233711422732">d</xref></sup> 	(44.15%)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0748233711422732">
<p>
<sup>a</sup>
<italic>p</italic> ≤ 0.05 is considered significant, <italic>p</italic> &gt; 0.05 is considered nonsignificant (NS).</p>
</fn>
<fn id="table-fn2-0748233711422732">
<p>
<sup>b</sup>Groups compared with control group I.</p>
</fn>
<fn id="table-fn3-0748233711422732">
<p>
<sup>c</sup>Groups II, III, and IV compared with control group I,<italic> *** p </italic>&lt; 0.001.</p>
</fn>
<fn id="table-fn4-0748233711422732">
<p>
<sup>d</sup>Groups II, III, and IV compared with control group I,<italic> ** p </italic>&lt; 0.01.</p>
</fn>
<fn id="table-fn5-0748233711422732">
<p>
<sup>e</sup>Groups compared with DMBA-treated group II.</p>
</fn>
<fn id="table-fn6-0748233711422732">
<p>
<sup>f</sup>Groups II, III, and IV compared with control group I,<italic> * p </italic>&lt; 0.05.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="table2-0748233711422732" position="float">
<label>Table 2.</label>
<caption>
<p>Mean ± SD for rat serum tumor markers and oxidative stress marker levels in different groups</p>
</caption>
<graphic alternate-form-of="table2-0748233711422732" xlink:href="10.1177_0748233711422732-table2.tif"/>
<table>
<thead>
<tr>
<th>Groups Parameter</th>
<th>Group I (<italic>N</italic> = 15)</th>
<th>Group II (<italic>n</italic> = 10)</th>
<th>Group III (<italic>n</italic> = 12)</th>
<th>Group IV (<italic>n</italic> = 10)</th>
<th>Group V (<italic>n</italic> = 11)</th>
</tr>
</thead>
<tbody>
<tr>
<td>TSA (ng/dL) (percentage change)</td>
<td>78.74 ± 11.59</td>
<td>154.12 ± 40.16<sup><xref ref-type="table-fn" rid="table-fn8-0748233711422732">a</xref><xref ref-type="table-fn" rid="table-fn9-0748233711422732">b</xref></sup> (95.73%)</td>
<td>115.41 ± 35.16<sup><xref ref-type="table-fn" rid="table-fn8-0748233711422732">a</xref><xref ref-type="table-fn" rid="table-fn10-0748233711422732">c</xref>,<xref ref-type="table-fn" rid="table-fn11-0748233711422732">d</xref><xref ref-type="table-fn" rid="table-fn12-0748233711422732">e</xref></sup> (46.57%)</td>
<td align="center">135.01 ± 28.69<sup><xref ref-type="table-fn" rid="table-fn8-0748233711422732">a</xref><xref ref-type="table-fn" rid="table-fn9-0748233711422732">b</xref>,dNS</sup> (71.46%)</td>
<td>111.04 ± 24.3<sup><xref ref-type="table-fn" rid="table-fn8-0748233711422732">a</xref><xref ref-type="table-fn" rid="table-fn9-0748233711422732">b</xref>,<xref ref-type="table-fn" rid="table-fn11-0748233711422732">d</xref><xref ref-type="table-fn" rid="table-fn10-0748233711422732">c</xref></sup> (41.02%)</td>
</tr>
<tr>
<td>CEA (ng/mL) (percentage change)</td>
<td>2.80 ± 0.52</td>
<td>8.05 ± 1.013<sup><xref ref-type="table-fn" rid="table-fn8-0748233711422732">a</xref><xref ref-type="table-fn" rid="table-fn10-0748233711422732">c</xref></sup> (187.05%)</td>
<td>5.52 ± 1.12<sup><xref ref-type="table-fn" rid="table-fn8-0748233711422732">a</xref><xref ref-type="table-fn" rid="table-fn10-0748233711422732">c</xref>,<xref ref-type="table-fn" rid="table-fn11-0748233711422732">d</xref><xref ref-type="table-fn" rid="table-fn10-0748233711422732">c</xref></sup> (96.83%)</td>
<td align="center">7.693 ± 1.55<sup><xref ref-type="table-fn" rid="table-fn8-0748233711422732">a</xref><xref ref-type="table-fn" rid="table-fn10-0748233711422732">c</xref>,dN.S.</sup> (174.32%)</td>
<td>5.83 ± 1.33<sup><xref ref-type="table-fn" rid="table-fn8-0748233711422732">a</xref><xref ref-type="table-fn" rid="table-fn10-0748233711422732">c</xref>,<xref ref-type="table-fn" rid="table-fn11-0748233711422732">d</xref><xref ref-type="table-fn" rid="table-fn10-0748233711422732">c</xref></sup> (107.88%)</td>
</tr>
<tr>
<td>NO (µmol/L) (percentage change)</td>
<td align="center">65.9 ± 7.355</td>
<td align="center">133.9 ± 7.52<sup><xref ref-type="table-fn" rid="table-fn8-0748233711422732">a</xref><xref ref-type="table-fn" rid="table-fn9-0748233711422732">b</xref></sup> (103.187%)</td>
<td>87.83 ± 6.28<sup><xref ref-type="table-fn" rid="table-fn8-0748233711422732">a</xref><xref ref-type="table-fn" rid="table-fn9-0748233711422732">b</xref>,<xref ref-type="table-fn" rid="table-fn11-0748233711422732">d</xref><xref ref-type="table-fn" rid="table-fn9-0748233711422732">b</xref></sup> (33.277%)</td>
<td align="center">127.6 ± 8.54<sup><xref ref-type="table-fn" rid="table-fn8-0748233711422732">a</xref><xref ref-type="table-fn" rid="table-fn9-0748233711422732">b</xref>,dN.S</sup> (93.63%)</td>
<td align="center">82.7 ± 8.53<sup><xref ref-type="table-fn" rid="table-fn8-0748233711422732">a</xref><xref ref-type="table-fn" rid="table-fn9-0748233711422732">b</xref>,<xref ref-type="table-fn" rid="table-fn11-0748233711422732">d</xref><xref ref-type="table-fn" rid="table-fn9-0748233711422732">b</xref></sup> (25.49%)</td>
</tr>
<tr>
<td>MDA (nmol/mL) (percentage change)</td>
<td>5.44 ± 0.73</td>
<td align="center">8.327 ± 1.845<sup><xref ref-type="table-fn" rid="table-fn8-0748233711422732">a</xref><xref ref-type="table-fn" rid="table-fn9-0748233711422732">b</xref></sup> (53.07%)</td>
<td align="center">6.811 ± 1.208<sup><xref ref-type="table-fn" rid="table-fn8-0748233711422732">a</xref><xref ref-type="table-fn" rid="table-fn10-0748233711422732">c</xref>,<xref ref-type="table-fn" rid="table-fn11-0748233711422732">d</xref><xref ref-type="table-fn" rid="table-fn12-0748233711422732">e</xref></sup> (25.2%)</td>
<td align="center">7.277 ± 0.912<sup><xref ref-type="table-fn" rid="table-fn8-0748233711422732">a</xref><xref ref-type="table-fn" rid="table-fn9-0748233711422732">b</xref>,dN.S.</sup> (33.77%)</td>
<td>6.67 ± 0.85<sup><xref ref-type="table-fn" rid="table-fn8-0748233711422732">a</xref><xref ref-type="table-fn" rid="table-fn10-0748233711422732">c</xref>,<xref ref-type="table-fn" rid="table-fn11-0748233711422732">d</xref><xref ref-type="table-fn" rid="table-fn10-0748233711422732">c</xref></sup> (22.61%)</td>
</tr>
<tr>
<td>Total antioxidant (mM/L) (percentage change)</td>
<td>2.71 ± 0.166</td>
<td>2.43 ± 0.229 <sup><xref ref-type="table-fn" rid="table-fn8-0748233711422732">a</xref><xref ref-type="table-fn" rid="table-fn10-0748233711422732">c</xref></sup> (−10.33%)</td>
<td>2.62 ± 0.149<sup><xref ref-type="table-fn" rid="table-fn8-0748233711422732">a</xref>NS,<xref ref-type="table-fn" rid="table-fn11-0748233711422732">d</xref><xref ref-type="table-fn" rid="table-fn12-0748233711422732">e</xref></sup> (−3.32%)</td>
<td>2.39 ± 0.47<sup><xref ref-type="table-fn" rid="table-fn8-0748233711422732">a</xref>NS,dNS</sup> (−11.808%)</td>
<td>2.64 ± 0.23<sup><xref ref-type="table-fn" rid="table-fn8-0748233711422732">a</xref>NS,<xref ref-type="table-fn" rid="table-fn11-0748233711422732">d</xref><xref ref-type="table-fn" rid="table-fn12-0748233711422732">e</xref></sup> (−2.58%)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn7-0748233711422732">
<p>TSA: total sialic acid, CEA: carcinoembryonic antigen, NO: nitric oxide, MDA: malondialdhyde.</p>
</fn>
<fn id="table-fn8-0748233711422732">
<p>
<sup>a</sup>Groups compared with control group I.</p>
</fn>
<fn id="table-fn9-0748233711422732">
<p>
<sup>b</sup>
<italic>p</italic> ≤ 0.05 is considered significant; <italic>p</italic> &gt; 0.05 is considered nonsignificant (NS). <italic>p </italic>&lt; 0.001.</p>
</fn>
<fn id="table-fn10-0748233711422732">
<p>
<sup>c</sup>
<italic>p</italic> ≤ 0.05 is considered significant; <italic>p</italic> &gt; 0.05 is considered nonsignificant (NS). <italic>p </italic>&lt; 0.01.</p>
</fn>
<fn id="table-fn11-0748233711422732">
<p>
<sup>d</sup>Groups compared with DMBA-treated group II.</p>
</fn>
<fn id="table-fn12-0748233711422732">
<p>
<sup>e</sup>
<italic>p</italic> ≤ 0.05 is considered significant; <italic>p</italic> &gt; 0.05 is considered nonsignificant (NS). <italic>p </italic>&lt; 0.05.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="table3-0748233711422732" position="float">
<label>Table 3.</label>
<caption>
<p>Mean ± SD for rat serum prolactin and estradiol levels in the different groups</p>
</caption>
<graphic alternate-form-of="table3-0748233711422732" xlink:href="10.1177_0748233711422732-table3.tif"/>
<table>
<thead>
<tr>
<th>Groups Parameter</th>
<th>Group I (<italic>n</italic> = 15)</th>
<th>Group II (<italic>n</italic> = 10)</th>
<th>Group III (<italic>n</italic> = 12)</th>
<th>Group IV (<italic>n</italic> = 10)</th>
<th>Group V (<italic>n</italic> = 11)</th>
</tr>
</thead>
<tbody>
<tr>
<td>Prolactin (ng/mL) (percentage change)</td>
<td>2.2 ± 0.5</td>
<td>3.08 ± 0.58 <sup><xref ref-type="table-fn" rid="table-fn13-0748233711422732">a</xref><xref ref-type="table-fn" rid="table-fn14-0748233711422732">b</xref></sup> (40%)</td>
<td>2.676 ± 0.67 <sup><xref ref-type="table-fn" rid="table-fn13-0748233711422732">a</xref>NS,<xref ref-type="table-fn" rid="table-fn14-0748233711422732">b</xref>NS</sup> (21.63%)</td>
<td>2.89 ± 0.73<sup><xref ref-type="table-fn" rid="table-fn13-0748233711422732">a</xref><xref ref-type="table-fn" rid="table-fn16-0748233711422732">d</xref>,<xref ref-type="table-fn" rid="table-fn14-0748233711422732">b</xref>NS</sup> (31.5%)</td>
<td>2.59 ± 0.49<sup><xref ref-type="table-fn" rid="table-fn13-0748233711422732">a</xref>NS <xref ref-type="table-fn" rid="table-fn14-0748233711422732">b</xref><xref ref-type="table-fn" rid="table-fn16-0748233711422732">d</xref></sup> (17.73%)</td>
</tr>
<tr>
<td>Estradiol (pg/mL) (percentage change)</td>
<td>51.2 ± 15.81</td>
<td>113.3 ± 6.65<sup><xref ref-type="table-fn" rid="table-fn13-0748233711422732">a</xref><xref ref-type="table-fn" rid="table-fn15-0748233711422732">c</xref></sup> (121.29%)</td>
<td>41.34 ± 13.55<sup><xref ref-type="table-fn" rid="table-fn13-0748233711422732">a</xref>NS,<xref ref-type="table-fn" rid="table-fn14-0748233711422732">b</xref><xref ref-type="table-fn" rid="table-fn15-0748233711422732">c</xref></sup> (−19.26%)</td>
<td>93.16 ± 21.26<sup><xref ref-type="table-fn" rid="table-fn13-0748233711422732">a</xref><xref ref-type="table-fn" rid="table-fn15-0748233711422732">c</xref>,<xref ref-type="table-fn" rid="table-fn14-0748233711422732">b</xref>NS</sup> (81.95%)</td>
<td>57.09 ± 17.47<sup><xref ref-type="table-fn" rid="table-fn13-0748233711422732">a</xref>NS, <xref ref-type="table-fn" rid="table-fn14-0748233711422732">b</xref><xref ref-type="table-fn" rid="table-fn14-0748233711422732">b</xref></sup> (11.5%)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn13-0748233711422732">
<p>
<sup>a</sup>Groups compared with control group I.</p>
</fn>
<fn id="table-fn14-0748233711422732">
<p>
<italic>
<sup>b</sup>
</italic>
<italic>p</italic> ≤ 0.05 is considered significant; <italic>p</italic> &gt; 0.05 is considered nonsignificant (NS). <italic>p </italic>&lt; 0.01.</p>
</fn>
<fn id="table-fn15-0748233711422732">
<p>
<sup>c</sup>Groups compared with DMBA treated group II.</p>
</fn>
<fn id="table-fn16-0748233711422732">
<p>
<italic>
<sup>d</sup>
</italic>
<italic>p</italic> ≤ 0.05 is considered significant; <italic>p</italic> &gt; 0.05 is considered nonsignificant (NS).<italic> p </italic>&lt; 0.05</p>
</fn>
<fn id="table-fn17-0748233711422732">
<p>
<italic>
<sup>e</sup>
</italic>
<italic>p</italic> ≤ 0.05 is considered significant; <italic>p</italic> &gt; 0.05 is considered nonsignificant (NS).<italic> p</italic> &lt;0.001</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Histopathological examinations of the mammary glands showed that the cells of mammary gland of control animals showed for most parts two layers of cells. These cells showed the presence of long spindle-shaped nuclei especially the superficial cells. The lumen of the alveoli of the mammary glands appeared clear without any cell debris or any secretion (<xref ref-type="fig" rid="fig1-0748233711422732">Figure 1</xref>). <xref ref-type="fig" rid="fig2-0748233711422732">Figure 2A</xref> and B shows light micrograph of mammary gland epithelia of rats injected with DMBA (Group II), with breast carcinoma with highly cellular growth and detachment cancerous cells inside the lumen of the alveoli. In the Group III, treated with selenium and DMBA, during the experiment 5 of 15 died and 10 of 15 had no malignant observation in hematoxylin and eosin H&amp;E section but as shown in <xref ref-type="fig" rid="fig3-0748233711422732">Figures 3A</xref> and B there is dilation of ducts that formed cysts which displayed apocrine hyperplasia and metaplasia. Examination of the mammary alveoli of rats protected with Genistin against the carcinogenicity of DMBA (Group IV) in <xref ref-type="fig" rid="fig3-0748233711422732">Figure 3C</xref> illustrates the desquamation in the breast carcinoma leaving only one or two layers and the nuclei were relatively dense. The overall appearance of the epithelium of mammary gland alveoli was much like that of the control animals. <xref ref-type="fig" rid="fig3-0748233711422732">Figure 3D</xref> shows that the mammary alveoli of the rat Group V consist of two cell layers and the lumen was also clear. The desquamation of the breast carcinoma leaving only one or two layers and the nuclei were relatively dense. So the overall appearance of mammary alveoli of rats protected with genistin in combination with selenium against the carcinogenicity of DMBA was much like that of the control animals.</p>
<fig id="fig1-0748233711422732" position="float">
<label>Figure 1.</label>
<caption>
<p>Light micrograph showing mammary gland epithelia of control rat (Group I) which showed two layers of epithelial cells (EC) surrounding the lumen (L) of the alveoli (AV) embedded in adipose tissue (fat cell [FC]). Hematoxylin and eosin (×100).</p>
</caption>
<graphic xlink:href="10.1177_0748233711422732-fig1.tif"/>
</fig>
<fig id="fig2-0748233711422732" position="float">
<label>Figure 2.</label>
<caption>
<p>Light micrograph of mammary gland epithelia of rats injected with DMBA (Group II). (A) Breast carcinoma with highly cellular growth and detachment cancerous cells inside the lumen of the alveoli (arrow; hematoxylin and eosin [H&amp;E] ×100). (B) Breast carcinoma. Note the highly cellular epithelial tissue between the arrows and the invasion of this carcinoma to the adjacent stroma (H&amp;E, ×250).</p>
</caption>
<graphic xlink:href="10.1177_0748233711422732-fig2.tif"/>
</fig>
<fig id="fig3-0748233711422732" position="float">
<label>Figure 3.</label>
<caption>
<p>(A) Light micrograph of a section of the mammary gland epithelia of rats injected with DMBA and treated with selenium (group III). (B) The hyperplasia of epithelial cells (arrowhead) surrounding the lumen of the alveoli containing a central amorphous eosinophilic necrosis (arrows). (C) Light micrograph of a section in the mammary gland epithelia of rat injected with DMBA and treated with genistin (group IV) and rats injecxted with DMBA and treated with genistin and selenium (groupV). (D) Two layers of epithelial cells (EC) surrounding a clear dilated lumen (L) of the alveoli (AV) of the control rat. (hematoxylin and eosin, × 100).</p>
</caption>
<graphic xlink:href="10.1177_0748233711422732-fig3.tif"/>
</fig>
</sec>
<sec id="section7-0748233711422732">
<title>Discussion</title>
<p>DMBA-induced mammary gland tumor in rodents has been widely used as an animal model for the development of chemopreventive drugs for breast cancer in humans (<xref ref-type="bibr" rid="bibr47-0748233711422732">Mehta, 2000</xref>). In our study, we injected DMBA at the age of 57 days due to susceptibility of the mammary gland to DMBA carcinogenesis is strongly age-dependent, being maximal when the drug is administered to rats between the age of 45 and 60 days, the age of the beginning of sexual maturity (Grubbs et al., <xref ref-type="bibr" rid="bibr26-0748233711422732">1986</xref>). </p>
<p>In the present study, the DMBA group exhibited a significant reduction in the body weight as a result of DMBA administration when compared with the control group. This is in accordance with the result of <xref ref-type="bibr" rid="bibr13-0748233711422732">Davis and Kuttan (2001</xref>) who stated that the generation of reactive oxygen species (ROS) and the peroxidation of membrane lipids are well associated with the reduction in body weight. Moreover, at high concentrations, ROS can be important mediators of damage to cell structures, including lipids and membranes, proteins and nucleic acids (<xref ref-type="bibr" rid="bibr58-0748233711422732">Poli et al., 2004</xref>). Significant increase in the body weight was observed in genistin-alone-treated group and genistin/selenium–treated group compared with DMBA group. This may be due to the increase in the total antioxidant level where selenium and genistin have antioxidant activity. Increased antioxidant may be a result of a protective mechanism that develops against free radical damage, maintaining the normal biochemical process.</p>
<p>Our results revealed significant reduction in total antioxidant level in the serum of DMBA Group II compared with the control group. This result supported by <xref ref-type="bibr" rid="bibr24-0748233711422732">Giri et al. (1995</xref>) who found that toxic manifestation of DMBA is associated with its oxidative metabolism, leading to the formation of reactive metabolites (epoxides and quinines) capable of generating free radicals. So the oxidative stress results from the excessive production of ROS that exhaust antioxidant defenses (<xref ref-type="bibr" rid="bibr32-0748233711422732">Hussein et al., 2005</xref>). </p>
<p>The serum level of total antioxidant in selenium-treated Group (IV) or genistin-treated Group (III) and genistin/selenium–treated Group (V) in this study was close to the value of the control group, and it is supported by <xref ref-type="bibr" rid="bibr5-0748233711422732">Banerjee et al. (2008</xref>) and <xref ref-type="bibr" rid="bibr23-0748233711422732">Gabrashanska et al., (2010</xref>). Genistein protects cells against ROS by scavenging free radicals and reducing the expression of stress–response-related genes (<xref ref-type="bibr" rid="bibr80-0748233711422732">Zhou and Lee, 1998</xref>). Moreover, because of its antioxidant capacity, genistein has an effect on the activation of the transcription factors, Nrf1 and Nrf2, which have been implicated in the regulation of genes involved in response to oxidative stress (<xref ref-type="bibr" rid="bibr30-0748233711422732">Hernandez-Montes et al., 2006</xref>).</p>
<p>Diet with selenium could be beneficial in the treatment of diseases correlated with considerable oxidative stress (<xref ref-type="bibr" rid="bibr23-0748233711422732">Gabrashanska et al., 2010</xref>). Also selenium plays an important role in a variety of biochemical reactions as a cofactor of the glutathione peroxidase enzyme (Chappuis and Poupon,<xref ref-type="bibr" rid="bibr9-0748233711422732">1991</xref>), which also prevents the initiation and progress of neoplastic events by protecting cells against hydroperoxide ions, causing free radical formation (<xref ref-type="bibr" rid="bibr42-0748233711422732">Lee et al., 2000</xref>; Madeja et al., 2005). These results indicate the ameliorative effect of genistin and selenium under these conditions.</p>
<p>The extent of lipid peroxidation was assessed by measuring thiobarbituric acid reactive substances (TBARS) called MDA (<xref ref-type="bibr" rid="bibr79-0748233711422732">Zhang et al., 2006</xref>). Our results showed that, serum MDA and NO levels were significantly elevated in the DMBA group versus the control group. These results were in agreement with the results of many authors (<xref ref-type="bibr" rid="bibr34-0748233711422732">Jang and Kim, 2002</xref>; <xref ref-type="bibr" rid="bibr40-0748233711422732">Kumaraguruparan et al., 2002</xref>; <xref ref-type="bibr" rid="bibr48-0748233711422732">Moselhy and Al mslmani, 2008</xref>) who found an elevation in the levels of MDA and NO in serum and breast tissues of DMBA-injected rats.</p>
<p>Concerning the results of MDA and NO levels, a little reduction in the serum MDA and NO levels were shown in selenium group, and much reduction in both genistin/selenium group and in the rats of genistin group in comparing with nontreated rats (DMBA group). </p>
<p>Genistein inhibits tumor promoter, 12-O-tetradecanoylphorbol-13-acetate–induced hydrogen peroxide production as well as its function in human polymorphonuclear leukocytes and HL-60 cells (<xref ref-type="bibr" rid="bibr63-0748233711422732">Rotondo et al., 2007</xref>). Selenium-containing compounds can increase the activity of glutathione peroxidase which catalyzes the reduction in H<sub>2</sub>O<sub>2</sub> and organic hydroperoxides (<xref ref-type="bibr" rid="bibr62-0748233711422732">Reddy et al., 1988</xref>). Glutathione peroxidase is a selenium-containing enzyme that is also effective in catalyzing the decomposition of hydrogen peroxides and lipid peroxides (<xref ref-type="bibr" rid="bibr54-0748233711422732">Park and Floyd 1992</xref>). </p>
<p>Results of this study suggested that selenium supplementation may reduce NO level, which agrees with the result obtained by <xref ref-type="bibr" rid="bibr59-0748233711422732">Prabhu et al. (2002</xref>). <xref ref-type="bibr" rid="bibr59-0748233711422732">Prabhu et al. (2002</xref>) suggested an inverse relationship between cellular Se status and iNOS expression in lipopolysaccharide (LPS)-stimulated RAW 264.7 cells and provided evidence for the beneficial effects of dietary Se supplementation in the prevention and/or treatment of oxidative-stress-mediated inflammatory diseases. </p>
<p>Sialic acid, a family of acetylated derivatives of neuraminic acid, is widely distributed in mammals in two forms—TSA and liposialic acid (LSA). Sialic acid occurs as a terminal component at the nonreducing end of carbohydrate chains of glycoproteins and glycolipids. A study carried by <xref ref-type="bibr" rid="bibr12-0748233711422732">Correale et al., (1992</xref>) showed that all groups of investigated breast cancer patients have mean values of sialic acid (SA) higher than healthy controls. </p>
<p>In the present study, serum TSA levels in the DMBA group were significantly increased by (95.73%) compared with the control group. Our findings of the increased serum levels of TSA in DMBA group were supported by the findings of Abd El-Aziz et al., (2005). On the other hand, our results showed a little reduction in the levels of TSA in the selenium-alone group (71.46%) and a high reduction in genistin-alone group (46.57%) also in combined genistin/selenium group by (41.02%) as compared with DMBA group. </p>
<p>CEA, a cell surface glycoprotein, elevated in patients with cancers in many organs and the elevation of serum levels of CEA was related to the five stages and the extent of the tumor. CEA is produced by breast cancer tissue and is then secreted in blood and various body fluids. CEA is the most widely used tumor marker (<xref ref-type="bibr" rid="bibr77-0748233711422732">Zamcheck, 1981</xref>). </p>
<p>In the current study, there was a significant increase in CEA in DMBA group versus control. Our results agree with the results obtained by <xref ref-type="bibr" rid="bibr14-0748233711422732">Dipple et al., (1990</xref>). On the other hand, in our study supplementation of selenium alone showed little reduction in CEA level and much reduction in CEA level in the combined genistin/selenium group or genistin group as compared with DMBA group (Group II). Our findings of the decreased CEA level in selenium groups were in agreement with <xref ref-type="bibr" rid="bibr44-0748233711422732">Liu et al. (1991</xref>). Also many experiments have shown that the chemopreventive effect of Se is due in part to its inhibitory effect on cell growth, DNA, RNA and protein synthesis in transformed cells (<xref ref-type="bibr" rid="bibr18-0748233711422732">El-Bayoumy, 2001</xref>). The ability of Se compounds to inhibit cell growth and to induce tumor cell apoptosis has now been widely demonstrated and is suggested to be a potential mechanism for cancer chemoprevention (<xref ref-type="bibr" rid="bibr73-0748233711422732">Wang et al., 2003</xref>). Results of this study suggested that the genistin supplementation may reduce CEA level; this result agrees with the result obtained by Pagliacci et al., (<xref ref-type="bibr" rid="bibr52-0748233711422732">1994</xref>) who demonstrated that genistein induces a G2/M cell cycle arrest in breast cancer cells, so the growth inhibition of cancer cells could be due to cell cycle arrest (<xref ref-type="bibr" rid="bibr21-0748233711422732">Farina et al., 2006</xref>; <xref ref-type="bibr" rid="bibr25-0748233711422732">Gossner et al., 2007</xref>; <xref ref-type="bibr" rid="bibr49-0748233711422732">Mukhopadhyay et al., 2006</xref>). </p>
<p>In our study, there was significant increase in the prolactin and estradiol levels in DMBA group compared with the control group. Our findings of the increased serum levels of prolactin and estradiol in DMBA group were supported by the findings of <xref ref-type="bibr" rid="bibr43-0748233711422732">Li et al. (2002</xref>) and Abd El-Aziz et al., (2005). Similar results were observed by <xref ref-type="bibr" rid="bibr43-0748233711422732">Li et al. (2002</xref>) and Abd El-Aziz et al. (2005) who reported increased marker levels of endocrine derangement, prolactin and estradiol. The possible roles of prolactin in mammary carcinogenesis include the induction of several apoptosis suppressor genes, stimulation of DNA synthesis and ability to increase ER sensitivity (<xref ref-type="bibr" rid="bibr38-0748233711422732">Krishnan et al., 2001</xref>). The increase in the serum estradiol level is not only in agreement with the previous reports of <xref ref-type="bibr" rid="bibr55-0748233711422732">Peck et al., (2002</xref>) and <xref ref-type="bibr" rid="bibr72-0748233711422732">Vondracek et al., (2002</xref>) but also suggests a linkage to mammary carcinogenesis. Moreover, our results showed a little reduction in the serum levels of prolactin and estradiol in the selenium group, much reduction in genistin group and in genistin/selenium group as compared with DMBA group. Results of this study suggest that each of genistin and selenium supplementation may reduce concentrations of estrogen. This finding is supported by <xref ref-type="bibr" rid="bibr75-0748233711422732">Wu et al. (2002</xref>) and <xref ref-type="bibr" rid="bibr66-0748233711422732">Shah et al. (2005</xref>).</p>
<p>In conclusion, it was clearly demonstrated that administration of DMBA (carcinogen) was associated with the development of mammary carcinoma, elevated levels of markers of tumorigenicity, endocrine derangement, and oxidative stress. Administration of genistin with or without selenium (Se) or selenium only was associated with decreased levels of tumorigenicity, endocrine derangement, and oxidative stress. The daily intake of genistin alone or genistin combined with selenium could protect or delay the development of breast cancer in the rats. Thus, it is essential for women to obtain a good antioxidant status by consuming a diet rich in genistin as well as selenium and adopt healthy behavior to reduce oxidative stress in order to prevent breast cancer. Also, combined intake of selenium and high isoflavones may achieve a greater chemopreventive effect than either compound supplemented individually.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure" id="fn1-0748233711422732">
<label>Funding</label>
<p>This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abd El Aziz</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Akl</surname>
<given-names>OA</given-names>
</name>
<name>
<surname>Ibrahim</surname>
<given-names>HK</given-names>
</name>
</person-group> (<year>2009</year>) <article-title>Impact of a health education intervention program about breast cancer among women in a semi-urban area in Alexandria</article-title>. <source>The Journal of the Egyptian Public Health Association</source> <volume>84</volume>
<issue>(1–2)</issue>: <fpage>219</fpage>–<lpage>243</lpage>.</citation>
</ref>
<ref id="bibr2-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abd El Aziz</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Hassan</surname>
<given-names>HA</given-names>
</name>
<name>
<surname>Mohamed</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Meki</surname>
<given-names>AMA</given-names>
</name>
<name>
<surname>Andel-Ghafar</surname>
<given-names>SKH</given-names>
</name>
<name>
<surname>Hussein</surname>
<given-names>MR</given-names>
</name>
</person-group> (<year>2005</year>) <article-title>The biochemical and morphological alterations following administration of melatonin, retinoic acid and Nigella sativa in mammary carcinoma: an animal model</article-title>. <source>International Journal of Experimental Pathology</source> <volume>86</volume>(<issue>6</issue>): <fpage>383</fpage>–<lpage>396</lpage>.</citation>
</ref>
<ref id="bibr3-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Allan</surname>
<given-names>CB</given-names>
</name>
<name>
<surname>Lacourciere</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Stadtman</surname>
<given-names>TC</given-names>
</name>
</person-group> (<year>1999</year>) <article-title>Responsiveness of selenoproteins to dietary selenium</article-title>. <source>Annual Review of Nutrition</source> <volume>19</volume>: <fpage>1</fpage>–<lpage>16</lpage>.</citation>
</ref>
<ref id="bibr4-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Allred</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Allred</surname>
<given-names>KF</given-names>
</name>
<name>
<surname>Ju</surname>
<given-names>YH</given-names>
</name>
<name>
<surname>Virant</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Helferich</surname>
<given-names>WG</given-names>
</name>
</person-group> (<year>2001a</year>) <article-title>Soy diets containing varying amounts of genistein stimulate growth of estrogen-dependent (MCF-7) tumors in a dose-dependent manner</article-title>. <source>Cancer Research</source> <volume>61</volume>(<issue>13</issue>): <fpage>5045</fpage>–<lpage>5050</lpage>.</citation>
</ref>
<ref id="bibr5-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Banerjee</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Sarkar</surname>
<given-names>FH</given-names>
</name>
</person-group> (<year>2008</year>) <article-title>Multi-targeted therapy of cancer by genistein</article-title>. <source>Cancer Letters</source> <volume>269</volume>(<issue>2</issue>): <fpage>226</fpage>–<lpage>242</lpage>.</citation>
</ref>
<ref id="bibr6-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barnes</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Grubbs</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Setchel</surname>
<given-names>KDR</given-names>
</name>
<name>
<surname>Clarson</surname>
<given-names>J</given-names>
</name>
</person-group> (<year>1990</year>) <article-title>Soybeans inhibit mammary tumor models of breast cancer</article-title>. <source>Progress in Clinical and Biological Research</source> <volume>347</volume>: <fpage>239</fpage>–<lpage>253</lpage>.</citation>
</ref>
<ref id="bibr7-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Borthwick</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Charnock-Jones</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>Tom</surname>
<given-names>BD</given-names>
</name>
<name>
<surname>Hull</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Teirney</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Phillips</surname>
<given-names>SC</given-names>
</name>
<etal/>
</person-group>. (<year>2003</year>) <article-title>Determination of the transcript profile of human endometrium</article-title>. <source>Molecular Human Reproduction</source> <volume>9</volume>(<issue>1</issue>): <fpage>19</fpage>–<lpage>33</lpage>.</citation>
</ref>
<ref id="bibr8-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cavalieri</surname>
<given-names>EL</given-names>
</name>
<name>
<surname>Stack</surname>
<given-names>DE</given-names>
</name>
<name>
<surname>Devanesan</surname>
<given-names>PD</given-names>
</name>
<name>
<surname>Todorovic</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Dwivedy</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Higginbotham</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>. (<year>1997</year>) <article-title>Molecular origin of cancer: catechol estrogen-3, 4-quinones as endogenous tumor initiators</article-title>. <source>Proceedings of National</source> <source>Academy Science USA</source> <volume>94</volume>(<issue>20</issue>): <fpage>10937</fpage>–<lpage>10942</lpage>.</citation>
</ref>
<ref id="bibr9-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chappuis</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Poupon</surname>
<given-names>J</given-names>
</name>
</person-group> (<year>1991</year>) <article-title>Le rôle du sélènium dans la défense du stress oxidatif</article-title>. <source>Cah Nutr Diet</source> <volume>26</volume>: <fpage>295</fpage>–<lpage>297</lpage>.</citation>
</ref>
<ref id="bibr10-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Charalabopoulos</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kotsalos</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Batistatou</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Charalabopoulos</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Vezyraki</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Peschos</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group>. (<year>2006</year>) <article-title>Selenium in serum and neoplastic tissue in breast cancer: correlation with CEA</article-title>. <source>British Journal of Cancer</source> <volume>95</volume>(<issue>6</issue>): <fpage>674</fpage>–<lpage>676</lpage>.</citation>
</ref>
<ref id="bibr11-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Mikhail</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>YW</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>G-Y</given-names>
</name>
<name>
<surname>Bondoc</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>CS</given-names>
</name>
</person-group> (<year>2000</year>) <article-title>Effects of vitamin E and selenium supplementation on esophageal adenocarcinogenesis in a surgical model with rats</article-title>. <source>Carcinogenesis</source> <volume>21</volume>(<issue>8</issue>): <fpage>1531</fpage>–<lpage>1536</lpage>.</citation>
</ref>
<ref id="bibr12-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Correale</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Abbate</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Gargano</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Catino</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Musci</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Dragone</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>De Lena</surname>
<given-names>M</given-names>
</name>
</person-group> (<year>1992</year>) <article-title>The detennination of sialic acid in cancer patients</article-title>. <source>Minerva Medica</source> <volume>83</volume>
<issue>(7–8)</issue>: <fpage>427</fpage>–<lpage>431</lpage>.</citation>
</ref>
<ref id="bibr13-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davis</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Kuttan</surname>
<given-names>G</given-names>
</name>
</person-group> (<year>2001</year>) <article-title>Effect of Withania somnifera on DMBA induced carcinogenesis</article-title>. <source>Journal of Ethnopharmacology</source> <volume>75</volume>
<issue>(2–3)</issue>: <fpage>165</fpage>–<lpage>168</lpage>.</citation>
</ref>
<ref id="bibr14-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dipple</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Bigger</surname>
<given-names>CA</given-names>
</name>
</person-group> (<year>1990</year>) <article-title>Polycyclic aromatic hydrocarbon carcinogens</article-title>. <source>Progress in Clinical and Biological Research</source> <volume>347</volume>: <fpage>109</fpage>–<lpage>127</lpage>.</citation>
</ref>
<ref id="bibr15-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Doll</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Peto</surname>
<given-names>R</given-names>
</name>
</person-group> (<year>1981</year>) <article-title>The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today</article-title>. <source>Journal of National Cancer Institute</source> <volume>66</volume>(<issue>6</issue>): <fpage>1192</fpage>–<lpage>1308</lpage>.</citation>
</ref>
<ref id="bibr16-0748233711422732">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Drury</surname>
<given-names>RAB</given-names>
</name>
<name>
<surname>Wallington</surname>
<given-names>EA</given-names>
</name>
</person-group> (<year>1980</year>) <source>Preparation and fixation of tissues in carleton’s histological technique</source>. <edition>4th ed</edition>. <publisher-name>New York: Oxford University Press</publisher-name>, <fpage>36</fpage>–<lpage>56</lpage>.</citation>
</ref>
<ref id="bibr17-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duhau</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Grassi</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Grouselle</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Enjalbert</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Grognet</surname>
<given-names>JM</given-names>
</name>
</person-group> (<year>1991</year>) <article-title>Enzyme Immunoassay for rat prolactin : application to the determination of plasma levels</article-title>. <source>Journal of Immunoassay</source> <volume>12</volume> (<issue>2</issue>): <fpage>233</fpage>–<lpage>250</lpage>.</citation>
</ref>
<ref id="bibr18-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>El-Bayoumy</surname>
<given-names>K</given-names>
</name>
</person-group> (<year>2001</year>) <article-title>The protective role of selenium on genetic damage and on cancer</article-title>. <source>Mutation Research</source> <volume>475</volume>
<issue>(1–2)</issue>: <fpage>123</fpage>–<lpage>139</lpage>.</citation>
</ref>
<ref id="bibr19-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Esterbauer</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Cheeseman</surname>
<given-names>KH</given-names>
</name>
</person-group> (<year>1990</year>) <article-title>Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal</article-title>. <source>Methods in Enzymology</source> <volume>186</volume>: <fpage>407</fpage>–<lpage>421</lpage>.</citation>
</ref>
<ref id="bibr20-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ethier</surname>
<given-names>SP</given-names>
</name>
</person-group> (<year>1995</year>) <article-title>Growth factor synthesis and human breast cancer progression</article-title>. <source>Journal of National Cancer Institute</source> <volume>87</volume>(<issue>13</issue>): <fpage>964</fpage>–<lpage>973</lpage>.</citation>
</ref>
<ref id="bibr21-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farina</surname>
<given-names>HG</given-names>
</name>
<name>
<surname>Pomies</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Alonso</surname>
<given-names>DF</given-names>
</name>
<name>
<surname>Gomez</surname>
<given-names>DE</given-names>
</name>
</person-group> (<year>2006</year>) <article-title>Antitumor and antiangiogenic activity of soy iso.avone genistein in mouse models of melanoma and breast cancer</article-title>. <source>Oncology Reports</source> <volume>16</volume>(<issue>4</issue>): <fpage>885</fpage>–<lpage>891</lpage>.</citation>
</ref>
<ref id="bibr22-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fishman</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Osborne</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Telang</surname>
<given-names>NT</given-names>
</name>
</person-group> (<year>1995</year>) <article-title>The role of estrogen in mammary carcinogenesis</article-title>. <source>Annals of New York Academy of Sciences</source> <volume>768</volume>: <fpage>91</fpage>–<lpage>100</lpage>.</citation>
</ref>
<ref id="bibr23-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gabrashanska</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Teodorova</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Petkova</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mihov</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Anisimova</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ivanov</surname>
<given-names>D</given-names>
</name>
</person-group> (<year>2010</year>) <article-title>Selenium supplementation at low doses contributes to the antioxidant status in Trichinella spiralis-infected rats</article-title>. <source>Parasitology Research</source> <volume>106</volume>(<issue>3</issue>):<fpage>561</fpage>–<lpage>570</lpage>.</citation>
</ref>
<ref id="bibr24-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Giri</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Abdulla</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Athar</surname>
<given-names>M</given-names>
</name>
</person-group> (<year>1995</year>) <article-title>Evidence that in situ generated reactive oxygen species act as a potent stage I tumor promoter in mouse skin</article-title>. <source>Biochemical and Biophysical Research Communications</source> <volume>209</volume>(<issue>2</issue>): <fpage>698</fpage>–<lpage>705</lpage>.</citation>
</ref>
<ref id="bibr25-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gossner</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Fogoros</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Griffith</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Kuenker</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>. (<year>2007</year>) <article-title>Genistein-induced apoptosis and autophagocytosis in ovarian cancer cells</article-title>. <source>Gynecologic Oncology</source> <volume>105</volume>(<issue>1</issue>): <fpage>23</fpage>–<lpage>30</lpage>.</citation>
</ref>
<ref id="bibr26-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grubbs</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Juliana</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Hill</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Whitaker</surname>
<given-names>LM</given-names>
</name>
</person-group> (<year>1986</year>) <article-title>Suppression by pregnancy of chemically induced preneoplastic cells of the rat mammary gland</article-title>. <source>Anticancer Research</source> <volume>6</volume>(<issue>6</issue>): <fpage>1395</fpage>–<lpage>400</lpage>.</citation>
</ref>
<ref id="bibr27-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guha</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Kwan</surname>
<given-names>M.L</given-names>
</name>
<name>
<surname>Quesenberry</surname>
<given-names>CP</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Weltzien</surname>
<given-names>EK</given-names>
</name>
<name>
<surname>Castillo</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Caan</surname>
<given-names>BJ</given-names>
</name>
</person-group> (<year>2009</year>) <article-title>Soy isoflavones and risk of cancer recurrence in a cohort of breast cancer survivors: the life after cancer epidemiology study</article-title>. <source>Breast Cancer Research and Treatment</source> <volume>118</volume>(<issue>2</issue>): <fpage>395</fpage>–<lpage>405</lpage>.</citation>
</ref>
<ref id="bibr29-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hardell</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Danell</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Angqvist</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Marklund</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Fredriksson</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zakari</surname>
<given-names>AL</given-names>
</name>
<etal/>
</person-group>. (<year>1993</year>) <article-title>Levels of selenium in plasma and glutathione peroxidase in erythrocytes and the risk of breast cancer</article-title>. <source>Biological Trace Element Research</source> <volume>36</volume>(<issue>2</issue>): <fpage>99</fpage>–<lpage>108</lpage>.</citation>
</ref>
<ref id="bibr30-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hernandez-Montes</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Pollard</surname>
<given-names>S.E</given-names>
</name>
<name>
<surname>Vauzour</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Jofre-Montseny</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Rota</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Rimbach</surname>
<given-names>G</given-names>
</name>
<etal/>
</person-group>. (<year>2006</year>) <article-title>Activation of glutathione peroxidase via Nrf1 mediates genistein’s protection against oxidative endothelial cell injury</article-title>. <source>Biochemical Biophysical Research Communications</source> <volume>346</volume>(<issue>3</issue>): <fpage>851</fpage>–<lpage>859</lpage>.</citation>
</ref>
<ref id="bibr31-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>YL</given-names>
</name>
<name>
<surname>Sheu</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>TH</given-names>
</name>
</person-group> (<year>1999</year>) <article-title>Association between oxidative stress and changes of trace elements in patients with breast cancer</article-title>. <source>Clin Biochem</source> <volume>32</volume>(<issue>2</issue>): <fpage>131</fpage>–<lpage>136</lpage>.</citation>
</ref>
<ref id="bibr32-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hussein</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Abu-Dief</surname>
<given-names>EE</given-names>
</name>
<name>
<surname>Abdel Reheem</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Abdel Rahman</surname>
<given-names>A</given-names>
</name>
</person-group> (<year>2005</year>) <article-title>Ultra structural evaluation of the radio protective effects of melatonin against X-ray induced skin damage in Albino rats</article-title>. <source>International Journal of Experimental Pathology</source> <volume>86</volume>(<issue>1</issue>): <fpage>45</fpage>–<lpage>55</lpage>.</citation>
</ref>
<ref id="bibr33-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iwasaki</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Inoue</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Otani</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Sasazuki</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kurahashi</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Miura</surname>
<given-names>T</given-names>
</name>
<etal/>
</person-group>. (<year>2008</year>) <article-title>Plasma isoflavone level and subsequent risk of breast cancer among japanese women: a nested case-control study from the japan public health center-based prospective study group</article-title>. <source>Journal of Clinical Oncology</source> <volume>26</volume>(<issue>10</issue>): <fpage>1677</fpage>–<lpage>1683</lpage>.</citation>
</ref>
<ref id="bibr34-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jang</surname>
<given-names>TJ</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>DK</given-names>
</name>
</person-group> (<year>2002</year>) <article-title>Inducible nitric oxide synthase expression of tumor and stromal cells is associated with the progression of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors</article-title>. <source>Cancer Letters</source> <volume>182</volume>(<issue>2</issue>): <fpage>121</fpage>–<lpage>126</lpage>.</citation>
</ref>
<ref id="bibr35-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koracevic</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Koracevic</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Djordjevic</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Andrejevic</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Cosic</surname>
<given-names>V</given-names>
</name>
</person-group> (<year>2001</year>) <article-title>Method for the measurement of antioxidant activity in human fluids</article-title>. <source>Journal of Clinical Pathology</source> <volume>54</volume>(<issue>5</issue>): <fpage>356</fpage>–<lpage>361</lpage>.</citation>
</ref>
<ref id="bibr36-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Korde</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>AH</given-names>
</name>
<name>
<surname>Fears</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Nomura</surname>
<given-names>AMY</given-names>
</name>
<name>
<surname>West</surname>
<given-names>D.W</given-names>
</name>
<name>
<surname>Kolonel</surname>
<given-names>LN</given-names>
</name>
<etal/>
</person-group>. (<year>2009</year>) <article-title>Childhood soy intake and breast cancer risk in Asian American women</article-title>. <source>Cancer Epidemiology, Biomakers &amp; Prevention</source> <volume>18</volume>(<issue>4</issue>): <fpage>1050</fpage>–<lpage>1059</lpage>.</citation>
</ref>
<ref id="bibr37-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kotsopoulos</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Vallis</surname>
<given-names>K A</given-names>
</name>
<name>
<surname>Poll</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ghadirian</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Kennedy</surname>
<given-names>G</given-names>
</name>
<etal/>
</person-group>. (<year>2010</year>) <article-title>Toenail selenium status and DNA repair capacity among female BRCA1 mutation carriers</article-title>. <source>Cancer Causes Control</source> <volume>21</volume>(<issue>5</issue>):<fpage>679</fpage>–<lpage>687</lpage>.</citation>
</ref>
<ref id="bibr38-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krishnan</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Buckley</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Reed</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Buckley</surname>
<given-names>AR</given-names>
</name>
</person-group> (<year>2001</year>) <article-title>Prolactin-Stimulated X-linked inhibitor of apoptosis protein expression during S phase cell cycle progression in rat Nb2 lymphoma cells</article-title>. <source>Endocrine</source> <volume>15</volume>(<issue>2</issue>): <fpage>177</fpage>–<lpage>186</lpage>.</citation>
</ref>
<ref id="bibr39-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuiper</surname>
<given-names>GG</given-names>
</name>
<name>
<surname>Lemmen</surname>
<given-names>JG </given-names>
</name>
<name>
<surname>Carlsson</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Corton</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Safe</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Van der Saag</surname>
<given-names>PT</given-names>
</name>
<etal/>
</person-group>. (<year>1998</year>) <article-title>Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta</article-title>. <source>Endocrinology</source> <volume>139</volume>(<issue>10</issue>): <fpage>4252</fpage>–<lpage>4263</lpage>.</citation>
</ref>
<ref id="bibr40-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumaraguruparan</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Subapriya</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Viswanathan</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Nagini</surname>
<given-names>S</given-names>
</name>
</person-group> (<year>2002</year>) <article-title>Tissue lipid peroxidation and antioxidant status in patients with adenocarcinoma of the breast</article-title>. <source>Clinica Chimica Acta</source> <volume>325</volume>
<issue>(1–2)</issue>: <fpage>165</fpage>–<lpage>170</lpage>.</citation>
</ref>
<ref id="bibr41-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kurzer</surname>
<given-names>MS</given-names>
</name>
</person-group> (<year>2002</year>) <article-title>Hormonal effects of soy in premenopausal women and men</article-title>. <source>The Journal of Nutrion</source> <volume>132</volume>: <fpage>570S</fpage>–<lpage>573S</lpage>.</citation>
</ref>
<ref id="bibr42-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Bar-Noy</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kwon</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Levine</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Stadtman</surname>
<given-names>TC</given-names>
</name>
<name>
<surname>Rhee</surname>
<given-names>SG</given-names>
</name>
</person-group> (<year>2000</year>) <article-title>Mammalian thioredoxin reductase: oxidation of the C-terminal cysteine/selenocysteine active site forms a thioselenide, and replacement of selenium with sulfur markedly reduces catalytic activity</article-title>. <source>Proceedings of National Academy of Sciences USA</source> <volume>97</volume>(<issue>6</issue>): <fpage>2521</fpage>–<lpage>2526</lpage>.</citation>
</ref>
<ref id="bibr43-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Weroha</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Tawfik</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>JJ</given-names>
</name>
</person-group> (<year>2002</year>) <article-title>Prevention of solely estrogen-induced mammary tumors in female aci rats by tamoxifen: evidence for estrogen receptor mediation</article-title>. <source>Journal of Endocrinology</source> <volume>175</volume>(<issue>2</issue>): <fpage>297</fpage>–<lpage>305</lpage>.</citation>
</ref>
<ref id="bibr44-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gilbert</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Parker</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Haschek</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Milner</surname>
<given-names>JA</given-names>
</name>
</person-group> (<year>1991</year>) <article-title>Inhibition of 7,12-dimethylbenz(a)anthracene-induced mammary tumors and DNA adducts by dietary selenite</article-title>. <source>Cancer Research</source> <volume>51</volume>(<issue>17</issue>): <fpage>4613</fpage>–<lpage>4617</lpage>.</citation>
</ref>
<ref id="bibr45-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maskarinec</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Verheus</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Steinberg</surname>
<given-names>FM</given-names>
</name>
<name>
<surname>Amato</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Cramer</surname>
<given-names>MK</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>RD</given-names>
</name>
<etal/>
</person-group>. (<year>2009</year>) <article-title>Various doses of soy isoflavones do not modify mammographic density in postmenopausal women</article-title>. <source>Journal of Nutrition</source> <volume>139</volume>(<issue>5</issue>): <fpage>981</fpage>–<lpage>986</lpage>.</citation>
</ref>
<ref id="bibr46-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maskarinec</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Takata</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Franke</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>SP</given-names>
</name>
</person-group> (<year>2004</year>) <article-title>A 2-year soy intervention in premenopausal women does not change mammographic densities</article-title>. <source>Journal of Nutrition</source> <volume>134</volume>(<issue>11</issue>): <fpage>3089</fpage>–<lpage>3094</lpage>.</citation>
</ref>
<ref id="bibr47-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mehta</surname>
<given-names>RG</given-names>
</name>
</person-group> (<year>2000</year>) <article-title>Experimental basis for the prevention of breast melanoma and breast cancer</article-title>. <source>Oncology Reports</source> <volume>16</volume>: <fpage>885</fpage>–<lpage>891</lpage>.</citation>
</ref>
<ref id="bibr48-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moselhy</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Al mslmani</surname>
<given-names>MAB</given-names>
</name>
</person-group> (<year>2008</year>) <article-title>Chemopreventive effect of lycopene alone or with melatonin against the genesis of oxidative stress and mammary tumors induced by 7,12 dimethyl(a) benzanthracene in sprague dawely female rats</article-title>. <source>Molecular and Cellular Biochemistry</source> <volume>319</volume>
<issue>(1–2)</issue>: <fpage>175</fpage>–<lpage>180</lpage>.</citation>
</ref>
<ref id="bibr49-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mukhopadhyay</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ballard</surname>
<given-names>BR</given-names>
</name>
<name>
<surname>Mukherjee</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kabir</surname>
<given-names>S M</given-names>
</name>
<name>
<surname>Das</surname>
<given-names>SK</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Beneficial effects of soy protein in the initiation and progression against dimethylbenz[a]anthracene-induced breast tumors in female rats</article-title>. <source>Molecular and Cellular Biochemistry</source> <volume>290</volume>
<issue>(1–2)</issue>: <fpage>169</fpage>–<lpage>176</lpage>.</citation>
</ref>
<ref id="bibr50-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nandi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Guzman</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J</given-names>
</name>
</person-group> (<year>1995</year>) <article-title>Hormones and mammary carcinogenesis in mice, rats, and humans: a unifying hypothesis</article-title>. <source>Proceedings of National Academy Sciences USA</source> <volume>92</volume>(<issue>9</issue>): <fpage>3650</fpage>–<lpage>3657</lpage>.</citation>
</ref>
<ref id="bibr51-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ohshima</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Bartsch</surname>
<given-names>H</given-names>
</name>
</person-group> (<year>1994</year>) <article-title>Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis</article-title>. <source>Mutation Research</source> <volume>305</volume>(<issue>2</issue>): <fpage>253</fpage>–<lpage>264</lpage>.</citation>
</ref>
<ref id="bibr52-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pagliacci</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Smacchia</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Migliorati</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Grignani</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Riccardi</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Nicoletti</surname>
<given-names>I</given-names>
</name>
</person-group> (<year>1994</year>) <article-title>Growth-inhibitory effects of the natural phyto-oestrogen genistein in MCF-7 human breast cancer cells</article-title>. <source>European Journal of Cancer</source> <volume>30</volume>: <fpage>1675</fpage>–<lpage>1682</lpage>.</citation>
</ref>
<ref id="bibr53-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Palomares</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Hopper</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Goldstein</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Lehman</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Storer</surname>
<given-names>BE</given-names>
</name>
<name>
<surname>Gralow</surname>
<given-names>JR</given-names>
</name>
</person-group> (<year>2004</year>) <article-title>Effect of soy isoflavones on breast proliferation in postmenopausal breast cancer survivors</article-title>. <source>Breast Cancer Research and Treatment</source> <volume>88</volume>: <fpage>4002</fpage>.</citation>
</ref>
<ref id="bibr54-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Floyd</surname>
<given-names>RA</given-names>
</name>
</person-group> (<year>1992</year>) <article-title>Lipid peroxidation products mediate the formation of 8-hydroxydeoxyguanosine in DNA</article-title>. <source>Free Radical Biology &amp; Medicine</source> <volume>12</volume>(<issue>4</issue>): <fpage>245</fpage>–<lpage>250</lpage>.</citation>
</ref>
<ref id="bibr55-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peck</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Hulka</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Poole</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Savitz</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Baird</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Richardson</surname>
<given-names>BE</given-names>
</name>
</person-group> (<year>2002</year>) <article-title>Steroid hormone levels during pregnancy and incidence of maternal breast cancer</article-title>. <source>Cancer Epidemiology Biomarkers and Prevention</source> <volume>11</volume>(<issue>4</issue>): <fpage>361</fpage>–<lpage>368</lpage>.</citation>
</ref>
<ref id="bibr56-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peto</surname>
<given-names>J</given-names>
</name>
</person-group> (<year>2001</year>) <article-title>Cancer epidemiology in the last century and the next decade</article-title>. <source>Nature</source> <volume>411</volume>: <fpage>390</fpage>–<lpage>395</lpage>.</citation>
</ref>
<ref id="bibr57-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Plucinsky</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Riley</surname>
<given-names>WM</given-names>
</name>
<name>
<surname>Prorok</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Alhadeff</surname>
<given-names>JA</given-names>
</name>
</person-group> (<year>1986</year>) <article-title>Total and lipid-associated serum sialic acid levels in cancer patients with different primary sites and differing degrees of metastatic involvement</article-title>. <source>Cancer</source> <volume>58</volume>(<issue>12</issue>): <fpage>2680</fpage>–<lpage>2685</lpage>.</citation>
</ref>
<ref id="bibr58-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poli</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Leonarduzzi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Biasi</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Chiarpotto</surname>
<given-names>F</given-names>
</name>
</person-group> (<year>2004</year>) <article-title>Oxidative stress and cell signaling</article-title>. <source>Current Medical Chemistry</source> <volume>11</volume>: <fpage>1163</fpage>–<lpage>1182</lpage>.</citation>
</ref>
<ref id="bibr59-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prabhu</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Zamamiri-Davis</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Stewart</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Sordillo</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Reddy</surname>
<given-names>CC</given-names>
</name>
</person-group> (<year>2002</year>) <article-title>Selenium deficiency increases the expression of inducible nitric oxide synthase in RAW 264.7 macrophages: role of nuclear factor-kappaB in up-regulation</article-title>. <source>The Biochemical Journal</source> <volume>366</volume>(<issue>pt 1</issue>): <fpage>203</fpage>–<lpage>209</lpage>.</citation>
</ref>
<ref id="bibr60-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qin</surname>
<given-names>LQ</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>PY</given-names>
</name>
<name>
<surname>Hoshi</surname>
<given-names>K</given-names>
</name>
</person-group> (<year>2006</year>) <article-title>Soyfood intake in the prevention of breast cancer risk in women: a meta-analysis of observational epidemiological studies</article-title>. <source>Journal of Nutritional Science and Vitaminology (Tokyo)</source> <volume>52</volume>(<issue>6</issue>): <fpage>428</fpage>–<lpage>436</lpage>.</citation>
</ref>
<ref id="bibr61-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rayman</surname>
<given-names>MP</given-names>
</name>
</person-group> (<year>2000</year>) <article-title>The importance of selenium to human health (review)</article-title>. <source>Lancet</source> <volume>356</volume>(<issue>9225</issue>): <fpage>233</fpage>–<lpage>241</lpage>.</citation>
</ref>
<ref id="bibr62-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reddy</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Sugie</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Maruyama</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Marra</surname>
<given-names>P</given-names>
</name>
</person-group> (<year>1988</year>) <article-title>Effect of dietary excess of inorganic selenium during initiation and postinitiation phases of colon carcinogenesis in F344 rats</article-title>. <source>Cancer Research</source> <volume>48</volume>(<issue>7</issue>): <fpage>1777</fpage>–<lpage>1780</lpage>.</citation>
</ref>
<ref id="bibr63-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rotondo</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Krauze-Brzosko</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Manarini</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Martelli</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Pecce</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Evangelista</surname>
<given-names>V</given-names>
</name>
<etal/>
</person-group>. (<year>2007</year>) <article-title>Inhibition by soya isoflavones of human polymorphonuclear leukocyte function: possible relevance for the beneficial effects of soya intake</article-title>. <source>British Journal Nutrition</source> <fpage>1</fpage>–<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr64-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rowland</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Faughnan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hoey</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wähälä</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Williamson</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Cassidy</surname>
<given-names>A</given-names>
</name>
</person-group> (<year>2003</year>) <article-title>Bioavailability of phytoestrogens</article-title>. <source>British Journal Nutrition</source> <volume>89</volume>(<issue>suppl 1</issue>): <fpage>S1</fpage>–<lpage>S15</lpage>.</citation>
</ref>
<ref id="bibr65-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saji</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hirose</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Toi</surname>
<given-names>M</given-names>
</name>
</person-group> (<year>2005</year>) <article-title>Clinical significance of estrogen receptor β in breast cancer</article-title>. <source>Cancer</source> <source>Chemotherapy and Pharmacology</source> <volume>56</volume>(<issue>suppl 1</issue>): <fpage>21</fpage>–<lpage>26</lpage>.</citation>
</ref>
<ref id="bibr66-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shah</surname>
<given-names>YM</given-names>
</name>
<name>
<surname>Kaul</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ip</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Rowan</surname>
<given-names>BG</given-names>
</name>
</person-group> (<year>2005</year>) <article-title>Attenuation of estrogen receptor α (ERα) signaling by selenium in breast cancer cells via downregulation of ERα gene expression</article-title>. <source>Breast Cancer Research and Treatment</source> <volume>92</volume>(<issue>3</issue>): <fpage>239</fpage>–<lpage>250</lpage>.</citation>
</ref>
<ref id="bibr67-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shiobara</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yoshida</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>KT</given-names>
</name>
</person-group> (<year>1998</year>) <article-title>Effects of dietary selenium species on Se concentrations in hair, blood, and urine</article-title>. <source>Toxicology and Applied Pharmacology</source> <volume>152</volume>(<issue>2</issue>): <fpage>309</fpage>–<lpage>314</lpage>.</citation>
</ref>
<ref id="bibr68-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tadjalli-Mehr</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Becker</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Rahu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Stengrevics</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kurtinaitis</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hakama</surname>
<given-names>M</given-names>
</name>
</person-group> (<year>2003</year>) <article-title>Randomized trial with fruits and vegetables in prevention of cancer</article-title>. <source>Acta Oncologica</source> <volume>42</volume>(<issue>4</issue>): <fpage>287</fpage>–<lpage>293</lpage>.</citation>
</ref>
<ref id="bibr69-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tato Rocha</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Cardenas Viedma</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Herrero Huerta</surname>
<given-names>E</given-names>
</name>
</person-group> (<year>1994</year>) <article-title>Selenio: implicaciones fisiopatológicas clínicas</article-title>. <source>Annales de medecine interne</source> <volume>2</volume>: <fpage>457</fpage>–<lpage>463</lpage>. </citation>
</ref>
<ref id="bibr70-0748233711422732">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Tietz</surname>
<given-names>NW</given-names>
</name>
</person-group> (<year>1995</year>) <source>Clinical guide to laboratory tests</source>. <edition>3rd ed</edition>. <publisher-loc>Philadelphia</publisher-loc>: <publisher-name>WB Saunders</publisher-name>, <fpage>216</fpage>–<lpage>217</lpage>.</citation>
</ref>
<ref id="bibr71-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vodovotz</surname>
<given-names>Y</given-names>
</name>
</person-group> (<year>1996</year>) <article-title>Modified microassay for serum nitrite and nitrate</article-title>. <source>BioTechniqaues</source> <volume>20</volume>(<issue>3</issue>): <fpage>390</fpage>–<lpage>394</lpage>.</citation>
</ref>
<ref id="bibr72-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vondracek</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kozubik</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Machala</surname>
<given-names>M</given-names>
</name>
</person-group> (<year>2002</year>) <article-title>Modulation of estrogen receptor-dependent reporter construct activation and G0/G1-S-phase transition by polycyclic aromatic hydrocarbons in human breast carcinoma MCF-7 cells</article-title>. <source>Toxicological Sciences</source> <volume>70</volume>(<issue>2</issue>): <fpage>193</fpage>–<lpage>201</lpage>.</citation>
</ref>
<ref id="bibr73-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>H</given-names>
</name>
</person-group> (<year>2003</year>) <article-title>Both calcium and ROS as common signals mediate Na<sub>2</sub>SeO<sub>3</sub>-induced apoptosis in SW480 human colonic carcinoma cells</article-title>. <source>Journal of Inorganic Biochemistry</source> <volume>97</volume>(<issue>2</issue>): <fpage>221</fpage>–<lpage>230</lpage>.</citation>
</ref>
<ref id="bibr74-0748233711422732">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Wild</surname>
<given-names>D</given-names>
</name>
</person-group> (<year>1994</year>) <source>The immunoassay handbook</source>. <publisher-name>New York: Stockton Press</publisher-name>, <fpage>444</fpage>.</citation>
</ref>
<ref id="bibr75-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>AH</given-names>
</name>
<name>
<surname>Wan</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Hankin</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Tseng</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Pike</surname>
<given-names>MC</given-names>
</name>
</person-group> (<year>2002</year>) <article-title>Adolescent and adult soy intake and risk of breast cancer in Asian-Americans</article-title>. <source>Carcinogenesis</source> <volume>23</volume>(<issue>9</issue>): <fpage>1491</fpage>–<lpage>1496</lpage>.</citation>
</ref>
<ref id="bibr76-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zachara</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Pilecki</surname>
<given-names>A</given-names>
</name>
</person-group> (<year>2001</year>) <article-title>Daily selenium intake by breast-fed infants and the selenium concentration in the milk of lactating women in western Poland</article-title>. <source>Medical Science Monitor</source> <volume>7</volume>(<issue>5</issue>): <fpage>1002</fpage>–<lpage>1004</lpage>.</citation>
</ref>
<ref id="bibr77-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zamcheck</surname>
<given-names>N</given-names>
</name>
</person-group> (<year>1981</year>) <article-title>The expanding field of colorectal cancer markers CEA, the prototype</article-title>. <source>Cancer Bull</source> <volume>33</volume>: <fpage>141</fpage>–<lpage>151</lpage>.</citation>
</ref>
<ref id="bibr78-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zanetti</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Tazi</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Rosso</surname>
<given-names>S</given-names>
</name>
</person-group> (<year>2009</year>) <article-title>New data tell us more about cancer incidence in North Africa</article-title>. <source>European Journal of Cancer</source> <volume>46</volume>(<issue>3</issue>): <fpage>462</fpage>–<lpage>466</lpage>.</citation>
</ref>
<ref id="bibr79-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>YM</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>WM</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>YQ</given-names>
</name>
</person-group> (<year>2006</year>) <article-title>Experimental study on anti-tumor effect of extractive from Celastrus orbiculatus in vivo</article-title>. <source>Zhongguo Zhong Yao</source> <source>Za Zhi</source> <volume>31</volume>(<issue>18</issue>): <fpage>1514</fpage>–<lpage>1516</lpage>.</citation>
</ref>
<ref id="bibr80-0748233711422732">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>AS</given-names>
</name>
</person-group> (<year>1998</year>) <article-title>Mechanism for the suppression of the mammalian stress response by genistein, an anticancer phytoestrogen from soy</article-title>. <source>Journal of National Cancer Institute</source> <volume>90</volume>(<issue>5</issue>): <fpage>381</fpage>–<lpage>388</lpage>. </citation>
</ref>
</ref-list>
</back>
</article>